Commercial Strategy Professional
Ping Li joined Skysis in 2021 with expertise in commercial planning and experience in the business development process of biotechnology. Ping is well-versed in pre-launch marketing tactics, product positioning, market access strategy, and new product planning.
Prior to joining Skysis, Ping served in business development and research roles for Angion Biomedica Corp in San Francisco, CA, and Credo Diagnostics in Taipei, Taiwan.
EDUCATION AND PROFESSIONAL CERTIFICATION
Ping earned an MSc in Molecular Biology & Pathology of Viruses and a BSc in Biology from the Imperial College London in London, England.